-
NMTRQ Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
9 Meters Biopharma (NMTRQ)
Company Profile
Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 7.62 mm | 7.62 mm | 7.62 mm | 7.62 mm | 7.62 mm | 7.62 mm |
Cash burn (monthly) | 7.35 mm | 2.47 mm | 4.62 mm | 3.86 mm | 3.25 mm | 3.10 mm |
Cash used (since last report) | 169.52 mm | 56.96 mm | 106.69 mm | 89.14 mm | 75.00 mm | 71.63 mm |
Cash remaining | -161.89 mm | -49.34 mm | -99.07 mm | -81.52 mm | -67.38 mm | -64.01 mm |
Runway (months of cash) | -22.0 | -20.0 | -21.4 | -21.1 | -20.7 | -20.6 |
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 6.13 mm |
Total shares | 7.30 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Capital Point | 7.30 mm | $6.13 mm |